Your search returned 9 results.

Sort
Results
1.
1573PDPATIENT-DERIVED XENOGRAFTS ACCURATELY CAPTURE CLINICAL RESPONSES TO TREATMENT.
PMID:
  • 28171498
Year: 2014
Citation:
  • Annals of Oncology. 25(suppl_4):iv547, 2014 Sep 01
Institution:
  • Franklin Square Hospital Center
Department:
  • McGuire, William
  • Medical Oncology
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Ciznadija D, Davies A, Gaya A, Harris W, Hidalgo M, Katz A, Maki RG, McGuire W, Paz K, Sidransky D, Stebbing J, Vasquez-Dunddel D, Zacharoulis S
2.
Early breast cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up . MedStar authors:
  • Swain, Sandra M
PMID:
  • 38101773
Year: 2023
Citation:
  • Annals of Oncology. 2023 Dec 08
Department:
  • Associate Dean for Research Development
  • MedStar Health
Medline publication type:
  • Practice Guideline
Form of publication:
  • Journal Article
All authors:
  • Loibl S, Andre F, Bachelot T, Barrios CH, Bergh J, Burstein HJ, Cardoso LMJ, Carey LA, Dawood S, Del Mastro L, Denkert C, Fallenberg EM, Francis PA, Gamal-Eldin H, Gelmon K, Geyer CE, Gnant M, Guarneri V, Gupta S, Kim SB, Krug D, Martin M, Meattini I, Morrow M, Janni W, Paluch-Shimon S, Partridge A, Poortmans P, Pusztai L, Regan MM, Sparano J, Spanic T, Swain S, Tjulandin S, Toi M, Trapani D, Tutt A, Xu B, Curigliano G, Harbeck N
3.
Avoiding over- and undertreatment in patients with resected node-positive breast cancer with the use of gene expression signatures: are we there yet?. [Review] MedStar authors:
  • Swain, Sandra
PMID:
  • 31131397
Year: 2019
Citation:
  • Annals of Oncology. 30(7):1044-1050, 2019 07 01.
Institution:
  • MedStar Health
Department:
  • Associate Dean for Research Development
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Bergh J, Foukakis T, Matikas A, Swain S
4.
Avoiding over- and undertreatment in patients with resected node-positive breast cancer with the use of gene expression signatures: are we there yet?. [Review] MedStar authors:
  • Swain, Sandra
PMID:
  • 31987370
Year: 2019
Citation:
  • Annals of Oncology. 30(7):1044-1050, 2019 Jul.
Institution:
  • Associate Dean for Research Development
Department:
  • MedStar Health
Medline publication type:
  • Journal Article
  • Review
Form of publication:
  • Journal Article
All authors:
  • Bergh J, Foukakis T, Matikas A, Swain S
5.
Incidence of central nervous system metastases in patients with HER2-positive metastatic breast cancer treated with pertuzumab, trastuzumab, and docetaxel: results from the randomized phase III study CLEOPATRA. MedStar authors:
  • Swain, Sandra M
PMID:
  • 24685829
Year: 2014
Citation:
  • Annals of Oncology. 25(6):1116-21, 2014 Jun.
Institution:
  • Washington Cancer Institute
Medline publication type:
  • Clinical Trial, Phase III
  • Journal Article
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't
Form of publication:
  • Journal Article
All authors:
  • Baselga J, Cortes J, Im YH, Lee LF, Miles D, Quah C, Swain SM
6.
Optimal sequencing of ibrutinib, idelalisib, and venetoclax in chronic lymphocytic leukemia: results from a multicenter study of 683 patients. MedStar authors:
  • Cruz, Allan-Louie
PMID:
  • 28453705
Year: 2017
Citation:
  • Annals of Oncology. 28(5):1050-1056, 2017 May 01
Institution:
  • MedStar Washington Hospital Center
Department:
  • Hematology/Oncology
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Barr PM, Brander DM, Cheson BD, Claxton DF, Cruz AL, Daniel C, Fanning M, Foon K, Gashonia L, Goy A, Henick Bachow S, Hill BT, Howlett C, Isaac K, Kennard KH, Kiselev P, Lamanna N, Lenhart J, Mato AR, Nabhan C, Pu JJ, Schuster SJ, Skarbnik AP, Svoboda J, Timlin C, Ujjani CS, Winter AM, Yacur M, Zent CS
7.
Management of cardiac disease in cancer patients throughout oncological treatment: ESMO consensus recommendations. MedStar authors:
  • Barac, Ana
PMID:
  • 31959335
Year: 2020
Citation:
  • Annals of Oncology. 31(2):171-190, 2020 02.
Institution:
  • MedStar Heart & Vascular Institutena
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Armenian S, Barac A, Blaes A, Calabro MG, Cardinale D, Carver J, Cipolla CM, Curigliano G, de Azambuja E, DeCara J, Dent S, ESMO Guidelines Committee. Electronic address: [email protected], Fradley M, Ganatra S, Harrison E, Herrmann J, Iakobishvili Z, Jordan K, Krone R, Ky B, Lancellotti P, Lenihan D, Lyon AR, Mitchell J, Moslehi J, Orecchia R, Patel A, Porter C, Witteles R, Zamorano JL
8.
Health-related quality-of-life assessment in CLEOPATRA, a phase III study combining pertuzumab with trastuzumab and docetaxel in metastatic breast cancer. MedStar authors:
  • Swain, Sandra M
PMID:
  • 23868905
Year: 2013
Citation:
  • Annals of Oncology. 24(10):2630-5, 2013 Oct.
Institution:
  • Washington Cancer Institute
Medline publication type:
  • Clinical Trial, Phase III
  • Journal Article
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't
Form of publication:
  • Journal Article
All authors:
  • Baselga J, Clark E, Cortes J, Im SA, Im YH, Knott A, Pivot X, Ross G, Swain SM
9.
Importance of gender in diffuse malignant peritoneal mesothelioma. MedStar authors:
  • Sugarbaker, Paul H
PMID:
  • 22056853
Year: 2012
Citation:
  • Annals of Oncology. 23(6):1494-8, 2012 Jun.
Institution:
  • MedStar Washington Hospital Center
Department:
  • Surgery/General Surgery
Medline publication type:
  • Journal Article
  • Multicenter Study
Form of publication:
  • Journal Article
All authors:
  • Cao C, Chua TC, Deraco M, Elias D, Glehen O, Levine EA, Moran BJ, Morris DL, Peritoneal Surface Malignancy Group, Piso P, Sugarbaker PH, Yan TD
Pages

Powered by Koha